Langerhans cell histiocytosis in a child with non-Hodgkin lymphoma

J Pediatr Hematol Oncol. 2010 Aug;32(6):e245-6. doi: 10.1097/MPH.0b013e3181e5e1c4.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adolescent
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Cyclophosphamide / therapeutic use
  • Cyclosporine / administration & dosage
  • Cytarabine / therapeutic use
  • Female
  • Histiocytosis, Langerhans-Cell / complications*
  • Histiocytosis, Langerhans-Cell / drug therapy
  • Histiocytosis, Langerhans-Cell / physiopathology
  • Humans
  • Lymphoma, Non-Hodgkin / complications*
  • Lymphoma, Non-Hodgkin / drug therapy
  • Lymphoma, Non-Hodgkin / physiopathology
  • Mercaptopurine / administration & dosage
  • Methotrexate / administration & dosage
  • Prednisolone / administration & dosage
  • Prednisone / therapeutic use
  • Vinblastine / administration & dosage
  • Vincristine / therapeutic use

Substances

  • Cytarabine
  • Vincristine
  • Vinblastine
  • Cyclosporine
  • Cyclophosphamide
  • Prednisolone
  • Mercaptopurine
  • Prednisone
  • Methotrexate

Supplementary concepts

  • COAP protocol